title: [Drug therapy of enuresis: sense/nonsense].
abstract: Nocturnal enuresis is a very common disorder in childhood. Classification and evaluation through patient history, physical examination, ultrasound of the kidneys and bladder including residual volume, dipstix and urine output protocol are necessary for successful treatment. Genetic, family-associated factors and a lowered nocturnal ADH-secretion are the main causes considered today. Next to behavioral therapy and conditioning, pharmacotherapy form the mainstay of therapy. Desmopressin is indicated when the nocturnal urinary volume exceeds the actual bladder capacity. Together with the right indication and optimal dosage, the therapy should be given for at least 4 to 6 weeks before step-by-step reduction, resulting in a success rate of up to 80%.
authors: Abteilung für Kinderurologie, Krankenhauses der Barmherzigen Schwestern, Linz. marcus.riccabona@bhs.at
authors: M
authors: M
authors: Riccabona
mesh_terms: D001521:Behavior Therapy; D002648:Child; D003131:Combined Modality Therapy; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D004775:Enuresis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D010348:Patient Care Team
chemical_list: D003894:Deamino Arginine Vasopressin